Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Kenneth Ataga, MD
Researcher Director
Division of Hematology/Oncology
University of Tennessee Health Science Center
956 Court Avenue
D324 Coleman Building
Memphis, Tennessee, United States
Dr. Ataga’s clinical interest is in classical hematology and hemoglobinopathies. He is the Director of the Center for Sickle Cell Disease at the University of Tennessee Health Science Center (UTHSC) at Memphis. His clinical research is focused on the vasculopathy of sickle cell disease, with an emphasis on pulmonary hypertension and renal complications, and coagulation activation in sickle cell disease. In addition, Dr. Ataga has a strong research interest in the development of new therapies for sickle cell disease. He conducts clinical trials in sickle cell disease funded by the National Institutes of Health and the Pharmaceutical Industry.
Representative Publications:
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
Pharmacologic Therapies for Sickle Cell Disease
+myBinderRelated Content
-
Johns Hopkins Berman Institute of BioethicsEstablished in 1995, the Berman Institut...
-
The Sickle Cell & Hemoglobinopathy Center of Western New YorkThe Sickle Cell & Hemoglobinopathy C...
-
Finding the Right Doctorhttps://www.youtube.com/watch?v=9WdVEAU5...
-
Sohail Rana, MDDr. Rana is Professor of Pediatrics at H...
-
Angela Rivers, MD, PhDDr. Rivers is the Director at Sickle Cel...
-
The Affordable Care Act Improves Healthcare Access and Utilization Among Young Adults with Sickle Cell DiseaseIntroduction: The Dependent Coverage Pro...
-
Webinar Series: Sickle Cell Science: Path to Progress – Genetic Therapies in Sickle Cell DiseaseTo commemorate Sickle Cell Awareness Mon...
